The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Neomile Corporate Advisory Ltd & Neomile Growth ....
AHCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.6 pts more than Nifty Microcap 250 and 5.0 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Neomile Corporate Advisory Limited and Neomile Growth Fund-Series 1 acquired 46,06,849 equity shares of Anlon Healthcare Ltd (equivalent to 8.67% of total voting share capital of 5,31,51,500 shares) through open market purchases between 3rd and 5th September 2025. This is a fresh entry — their holding was nil before the acquisition. The acquirer has explicitly confirmed they do not belong to the promoter or promoter group of the company. This filing represents an initial substantial acquisition that has been completed just below the next disclosure threshold of 10%.
A new institutional investor with a sizeable ~8.67% stake signals confidence in the company from a professional asset manager's fund, which could be viewed positively by retail investors. However, since the acquirer sits just under the 10% threshold, further accumulation could trigger additional SAST disclosures and potential market sensitivity.